{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:33:18Z","timestamp":1786120398547,"version":"build-2736575974"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1097\/wnf.0b013e31824d529b","type":"journal-article","created":{"date-parts":[[2012,3,16]],"date-time":"2012-03-16T06:03:40Z","timestamp":1331877820000},"page":"118-120","source":"Crossref","is-referenced-by-count":30,"title":["Opioid Antagonist Naltrexone for the Treatment of Pathological Gambling in Parkinson Disease"],"prefix":"10.1097","volume":"35","author":[{"given":"Domenico","family":"Bosco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Plastino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"Colica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Bosco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Span\u00f2","family":"Arianna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Vecchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Galati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Cristiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Consoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Consoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-4-20210203","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1017\/S0033291796003789","article-title":". Altered dopamine function in pathological gambling.","volume":"27","author":"Bergh","year":"1997","journal-title":"Psychol Med"},{"key":"R3-4-20210203","first-page":"869","article-title":"Fraile A, et al..","volume":"15","author":"Molina","year":"2000","journal-title":"Pathological gambling in Parkinsons disease: a behavioural manifestation of pharmacological treatment Mov Disord"},{"key":"R4-4-20210203","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1523\/JNEUROSCI.4643-03.2004","article-title":". Dopamine neurotransmission in the human striatum during monetary reward tasks.","volume":"24","author":"Zald","year":"2004","journal-title":"J Neuroscience"},{"key":"R5-4-20210203","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1001\/archneur.62.9.noc50009","article-title":". Pathological gambling caused by drugs used to treat Parkinsons disease.","volume":"62","author":"Dodd","year":"2005","journal-title":"Arch Neurol"},{"key":"R6-4-20210203","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/mds.10625","article-title":"Disabling repetitive behaviors in Parkinsons disease.","volume":"19","author":"Kurlan","year":"2004","journal-title":"Mov Disord"},{"key":"R7-4-20210203","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1212\/01.WNL.0000076478.45005.EC","article-title":"Pathological gambling associated with dopamine agonist therapy in Parkinsons disease.","volume":"61","author":"Driver-Dunckley","year":"2003","journal-title":"Neurology"},{"key":"R8-4-20210203","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/mds.21098","article-title":". Pathological gambling in Parkinsons disease improves on chronic subthalamic nucleus stimulation.","volume":"21","author":"Ardouin","year":"2006","journal-title":"Mov Disord"},{"key":"R10-4-20210203","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S0006-3223(01)01079-4","article-title":". Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling.","volume":"49","author":"Kim","year":"2001","journal-title":"Biol Psychiatry"},{"key":"R11-4-20210203","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1176\/appi.ajp.163.2.303","article-title":". Multicenter investigation of the opioid antagonist Nalmefene in the treatment of pathological gambling.","volume":"163","author":"Grant","year":"2006","journal-title":"Am J Psychiatry"},{"key":"R13-4-20210203","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","article-title":"Parkinsonism: onset, progression and mortality.","volume":"17","author":"Hoehn","year":"1967","journal-title":"Neurology"},{"key":"R14-4-20210203","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1001\/archneur.64.8.1089","article-title":"Medication-related impulse control and repetitive behaviours in Parkinson disease.","volume":"64","author":"Voon","year":"2007","journal-title":"Arch Neurol"},{"key":"R15-4-20210203","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/JCP.0b013e31802e98c3","article-title":"Quietapine in a case with Parkinson disease and pathological gambling.","volume":"27","author":"Sevincok","year":"2007","journal-title":"J Clin Psychopharmacol"},{"key":"R16-4-20210203","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/mds.21770","article-title":". Long-term follow-up of impulse control disorders in Parkinson disease.","volume":"23","author":"Mamikonyan","year":"2008","journal-title":"Mov Disord"},{"key":"R17-4-20210203","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1212\/01.wnl.0000243252.71365.81","article-title":"Repetitive and impulsive behaviors in treated Parkinson disease.","volume":"67","author":"Black","year":"2006","journal-title":"Neurology"},{"key":"R18-4-20210203","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1176\/ajp.156.11.1758","article-title":". Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial.","volume":"156","author":"Anton","year":"1999","journal-title":"Am J Psychiatry"},{"key":"R19-4-20210203","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/0024-3205(89)90589-4","article-title":"Role of opioid antagonists in treating intravenous cocaine abuse.","volume":"44","author":"Kosten","year":"1989","journal-title":"Life Sci"},{"key":"R20-4-20210203","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0166-2236(97)01204-6","article-title":"Orphanin FQnociceptin: a role in pain and analgesia, but so much more.","volume":"21","author":"Darland","year":"1998","journal-title":"Trends Neurosci"},{"key":"R21-4-20210203","doi-asserted-by":"crossref","first-page":"6659","DOI":"10.1523\/JNEUROSCI.0987-04.2004","article-title":". Blockade of nociceptinorphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behavior.","volume":"24","author":"Marti","year":"2004","journal-title":"J Neurosci"},{"key":"R22-4-20210203","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0306-4522(02)00050-7","article-title":". Nociceptinorphanin FQ receptors modulate glutamate extracellular levels in the substantia nigra pars reticulata. A microdialysis study in the awake freely moving rat.","volume":"112","author":"Marti","year":"2002","journal-title":"Neuroscience"},{"key":"R23-4-20210203","doi-asserted-by":"crossref","first-page":"9591","DOI":"10.1523\/JNEUROSCI.2546-05.2005","article-title":". Blockade of nociceptinorphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinsons disease.","volume":"25","author":"Marti","year":"2005","journal-title":"J Neurosci"}],"container-title":["Clinical Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/WNF.0b013e31824d529b","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:42:06Z","timestamp":1786048926000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002826-201205000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/wnf.0b013e31824d529b","relation":{},"ISSN":["0362-5664"],"issn-type":[{"value":"0362-5664","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}